Day: May 20, 2020

High concentration nitric oxide (150 ppm) is statistically significant compared to both low concentration nitric oxide (85 ppm) and control arms on both the primary endpoint and the key secondary endpointNo serious adverse events related to NO therapyThird consecutive successful pilot study in bronchiolitisGARDEN CITY, N.Y., May 20, 2020 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and gaseous NO for the treatment of solid tumors, today announced positive top-line results from its third pilot study in bronchiolitis patients that showed, on an intent-to-treat (ITT) basis, 150 parts per million (ppm)...

SOLANA BEACH, Calif., May 20, 2020 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the U.S. Food and Drug Administration (FDA) has conditionally accepted the proprietary brand name, “Gimoti,” for the Company’s nasal spray product candidate for the relief of symptoms in adult women with acute and recurrent diabetic gastroparesis as resubmitted in the 505(b)(2) New Drug Application (NDA).The name Gimoti (pronounced “jye-MOH-tee”) was developed in compliance with FDA’s Guidance for Industry, Contents of a Complete Submission for the Evaluation of Proprietary Names. Based on the development program, which included research with physicians and pharmacists, as well as an international name assessment, the Company believes...

New York City, May 20, 2020 (GLOBE NEWSWIRE) — Megalith Financial Acquisition Corp (NYSE: MFAC) (“MFAC” or the “Company”) today announced it has signed a non-binding letter of intent and expects to sign a definitive agreement to acquire a digital banking platform that is among the fastest growing in the country with several million accounts. The target company features an advanced, purpose-built platform via proprietary technology that provides a full suite of low-cost banking products including checking, savings, and credit cards to millennials and middle-income consumers.With attractive market tailwinds, industry-leading technology, and an innovative customer-acquisition model, MFAC management believes that the target company is well positioned to disrupt the U.S. banking market. The company expects to be EBITDA positive in fiscal...

Rapport financier annuel 2019 corrigé en page 4.AttachmentFIPP Rapport Financier 31-12-2019 corrigé en page 4

ACANTHE DEVELOPPEMENTSociété Européenne au capital de 19 991 141 euros2, rue de Bassano – 75116 Paris – RCS PARIS 735 620 205Tél : 01 56 52 45 00 – Fax : 01 53 23 10 11Paris, le 20 mai 2020Communiqué de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 10 juin 2020La Société annonce avoir mis à disposition du public les documents préparatoires à l’Assemblée générale mixte du 10 juin 2020, conformément aux dispositions de l’article R.225-73-1 du Code de commerce.Les documents préparatoires à l’Assemblée générale peuvent être consultés sur le site internet de la Société à l’adresse www.acanthedeveloppement.fr dans l’onglet “assemblées générales” de la rubrique “informations réglementées”.Pièce jointeAcanthe – Communiqué de mise à disposition des documents préparatoires...

DALLAS, May 20, 2020 (GLOBE NEWSWIRE) — CSW Industrials, Inc. (Nasdaq: CSWI) today reported results for the 2020 fiscal fourth quarter and fiscal full-year ended March 31, 2020.Company HighlightsManagement responding decisively to the global pandemic, acting in the best interest of all stakeholdersOperations deemed essential with minimal disruption and enhanced safeguards for employeesReported 10.2% and 9.3% growth in revenue and operating income, respectively, in fiscal year 2020, as compared to fiscal year 2019Reported fiscal year 2020 earnings per share of $2.95 as compared to fiscal year 2019 EPS of $2.96, with adjusted EPS of $3.20 compared to $2.77, respectivelyDemonstrated continued commitment to disciplined capital allocation strategy with $26.5 million of shares repurchased, $20.6 million in net debt repayments, and $8.1...